Perturbation by bacterial lipopolysaccharide of the metabolic processes of human cells in continuous culture.
D000225:Adenine / Q000378:metabolism*; D000596:Amino Acids / Q000378:metabolism*; D002460:Cell Line; D002478:Cells, Cultured / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004731:Endotoxins / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008926:Plicamycin / Q000494:pharmacology; D011135:Polysaccharides, Bacterial / Q000494:pharmacology; D011741:Pyrimidine Nucleosides / Q000378:metabolism*; D012694:Serine / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism; D014750:Vincristine / Q000494:pharmacology
D000596:Amino Acids; D004731:Endotoxins; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D011741:Pyrimidine Nucleosides; D003609:Dactinomycin; D012694:Serine; D014750:Vincristine; D003513:Cycloheximide; D007930:Leucine; D000225:Adenine; D008926:Plicamycin; D013936:Thymidine; D014529:Uridine